SEC Form 4 · accession 0001437749-17-010195
LIFECORE BIOMEDICAL, INC. \DE\ · LFCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Tobin
Director
Period of report
May 25, 2017
Accepted (ET)
May 26, 2017 · 7:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005286
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 25, 2017 | M | 5,282 | $13.50 | A | 44,459 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF2,F1,F3 | — | May 25, 2017 | M | 5,282 | D | May 25, 2017 | May 25, 2017 | Common Stock | 5,282 | 0 | D |
Explanation of responses
- F1The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.
- F2The restricted stock units were granted on May 25, 2016.
- F3The restricted stock units vested on May 25, 2017.